TANG CAPITAL MANAGEMENT LLC Diversified Active

Location: San Diego, CA

CIK: 0001232621 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value: $655M (100.0% shares, 0.0% debt)

Holdings (11)

— ODONATE THERAPEUTICS INC 45.5%

Value $298M Shares 15,514,566 Est. Cost $24.10 Unrealized —

RCKT ROCKET PHARMACEUTICALS INC 24.8%

Value $163M Shares 2,965,485 Est. Cost $16.31 Unrealized +123.5%

— APTEVO THERAPEUTICS INC 9.8%

Value $64.5M Shares 1,760,000 Est. Cost $36.65 Unrealized —

ANAB ANAPTYSBIO INC 8.6%

Value $56.52M Shares 2,628,678 Est. Cost $21.51 Unrealized +12.9%

— LA JOLLA PHARMACEUTICAL CO 5.6%

Value $36.49M Shares 9,405,490 Est. Cost $10.35 Unrealized —

CHRS COHERUS BIOSCIENCES INC 1.7%

Value $11.3M Shares 650,000 Est. Cost $17.90 Unrealized -0.5%

— VINCERA PHARMA INC 1.5%

Value $9.63M Shares 500,000 Est. Cost $19.26 Unrealized —

RLMD RELMADA THERAPEUTICS INC 1.0%

Value $6.414M Shares 200,000 Est. Cost $28.22 Unrealized +21.8%

— BCTG ACQUISITION CORP 0.8%

Value $5.363M Shares 468,750 Est. Cost $10.36 Unrealized —

EQ EQUILLIUM INC 0.5%

Value $3.21M Shares 600,000 Est. Cost $5.23 Unrealized 0.0%

— VINCERA PHARMA INC 0.2%

Value $1.09M Shares 330,205 Est. Cost $3.30 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ODONATE THERAPEUTICS INC	15,514,566	$298M	45.5%	$24.10	—	COM	676079106
RCKT	ROCKET PHARMACEUTICALS INC	2,965,485	$163M	24.8%	$16.31	+123.5%	COM	77313F106
—	APTEVO THERAPEUTICS INC	1,760,000	$64.5M	9.8%	$36.65	—	COM NEW	03835L207
ANAB	ANAPTYSBIO INC	2,628,678	$56.52M	8.6%	$21.51	+12.9%	COM	032724106
—	LA JOLLA PHARMACEUTICAL CO	9,405,490	$36.49M	5.6%	$10.35	—	COM	503459604
CHRS	COHERUS BIOSCIENCES INC	650,000	$11.3M	1.7%	$17.90	-0.5%	COM	19249H103
—	VINCERA PHARMA INC	500,000	$9.63M	1.5%	$19.26	—	UNIT 12/24/2025	92731L205
RLMD	RELMADA THERAPEUTICS INC	200,000	$6.414M	1.0%	$28.22	+21.8%	COM	75955J402
—	BCTG ACQUISITION CORP	468,750	$5.363M	0.8%	$10.36	—	COM	05492W103
EQ	EQUILLIUM INC	600,000	$3.21M	0.5%	$5.23	0.0%	COM	29446K106
—	VINCERA PHARMA INC	330,205	$1.09M	0.2%	$3.30	—	*W EXP 12/24/202	92731L114